She doesn't want to spend time fighting with her health insurer. After all, she's terminally ill. However, she said she ...

The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 ...

SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...

Q4 2024 Earnings Call Transcript March 31, 2025 Brainstorm Cell Therapeutics Inc. reports earnings inline with expectations.

After losing her husband to ALS, Indu Navar used her tech background to create real change. Learn how she built a data-driven ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

After her husband passed away from ALS, Indu Navar started an organization that uses AI to study ALS and other neurological ...